When is temporary pacing indicated in an adult patient with a history of cardiac disease undergoing cardiopulmonary resuscitation (CPR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Temporary Pacing in CPR

Temporary pacing is NOT recommended during cardiopulmonary resuscitation for asystolic cardiac arrest, as it does not improve survival and may delay effective chest compressions. 1

Pacing is Contraindicated in Asystolic Cardiac Arrest

  • Pacing for patients in asystole during CPR is Class III (not recommended) with Level of Evidence B. 1
  • Randomized controlled trials in both prehospital and hospital settings demonstrated no improvement in hospital admission rates or survival to discharge when pacing was attempted in asystolic patients. 1
  • Even when electrical capture is achieved in asystolic patients, electromechanical dissociation typically follows and survival is not improved. 2
  • Pacing attempts delay or interrupt chest compressions, which are the cornerstone of effective CPR. 1

When Pacing IS Indicated: Bradycardia Developing DURING CPR

If a patient develops acute symptomatic bradycardia or complete heart block DURING an ongoing resuscitation (not primary asystole), temporary pacing may be beneficial after atropine failure. 1

Treatment Algorithm for Bradycardia During CPR:

  1. First-line: Atropine 0.5-1 mg IV every 3-5 minutes (maximum 3 mg total) 1, 3

    • Atropine is unlikely to be effective for type II second-degree or third-degree AV block with wide QRS complex. 3
  2. Second-line if atropine fails:

    • Transcutaneous pacing (TCP) - Class IIa recommendation 1, 3
    • Dopamine infusion 5-20 mcg/kg/min IV 1, 3
    • Epinephrine infusion 2-10 mcg/min IV 1, 3
  3. Third-line: Transvenous pacing if TCP and medications fail (Class IIa) 1

Evidence Supporting Selective Pacing Use:

  • In patients who developed complete heart block or bradycardia DURING CPR (not primary asystole), transvenous pacing achieved electrical capture in 77% and successful resuscitation in one-third of cases. 2
  • Prehospital external pacing for hemodynamically significant bradycardia (heart rate <60, blood pressure <90 mmHg, unresponsive to atropine) resulted in 100% resuscitation rate and 83% survival in one prospective trial. 4
  • However, when bradycardia or asystole during cardiac arrest fails to respond to standard pharmacologic measures, it indicates severe myocardial damage and pacing rarely improves survival. 5

Critical Pitfalls to Avoid

  • Never delay chest compressions to attempt pacing in asystolic arrest. 1
  • Do not use synchronized cardioversion mode for asystole or pulseless VT—the device may not sense a QRS and fail to deliver a shock. 1
  • Immediate pacing might be considered in unstable patients with high-degree AV block when IV access is not available (Class IIb). 1
  • TCP serves only as a temporizing bridge and requires sedation/analgesia in conscious patients due to pain. 3

Special Circumstances in Cardiac Disease Patients

For patients with known cardiac disease undergoing CPR:

  • Acute anterior MI with complete AV block: Immediate temporary pacing is indicated as His-Purkinje necrosis causes cardiogenic shock unresponsive to atropine. 6
  • Post-cardiac surgery (aortic valve, tricuspid repair, VSD closure): Prophylactic temporary pacing may be warranted. 1, 6
  • Bifascicular block with anterior MI: Consider prophylactic temporary pacing. 1, 6

The key distinction is that pacing has no role in PRIMARY asystolic arrest but may be lifesaving for acute bradyarrhythmias that develop as a complication during resuscitation efforts in patients with viable myocardium. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Symptomatic Bradycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

External cardiac pacing during in-hospital cardiac arrest.

The American journal of cardiology, 1986

Guideline

Temporary Pacemaker Use in Clinical Practice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the most appropriate immediate treatment for a patient with bradycardia (heart rate of 38), intermittent lightheadedness, and a history of type 2 diabetes, who is currently asymptomatic?
What is the preferred treatment for symptomatic or unstable complete heart block, transcutaneous pacing or pharmacological therapy, such as atropine (anticholinergic) or isoproterenol (beta-adrenergic agonist)?
What is the recommended dose of atropine (anti-muscarinic agent) in cardiac arrest?
What is the role of Atropine (antimuscarinic agent) in treating asystole (flatline, cardiac arrest)?
What is the starting amperage for transcutaneous pacing in a patient with severe bradycardia and hypotension?
What could be causing left upper quadrant pain in a post-cholecystectomy patient triggered by eating fatty foods?
What are the recommended Sun Protection Factor (SPF) and Protection Grade of UVA (PA) ratings for sunscreen to protect against ultraviolet B (UVB) and ultraviolet A (UVA) rays?
What is the current status and recommendation for using autologous mesenchymal stem cell treatment for various medical conditions?
What is the Gleason classification in prostate cancer for a male patient over 50 with a family history of prostate cancer?
Can a patient with a history of substance abuse, currently experiencing withdrawal symptoms and being evaluated with the Clinical Institute Withdrawal Assessment (CIWA) scale, who is unsteady while walking, be considered to have an ataxic gait?
Can I continue taking risperidone (an antipsychotic medication) for my mental health condition if I restart atenolol (a beta-blocker) to manage my Postural Orthostatic Tachycardia Syndrome (POTS) symptoms?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.